Your browser doesn't support javascript.
loading
Analyzing the dynamics of meningococcal vaccinations initiatives by local government units in Poland (2017-2021) - Scope, challenges and recommendations.
Switalski, Jakub; Miazga, Wojciech; Wnuk, Katarzyna; Tatara, Tomasz; Olszewski, Pawel; Jankowski, Mateusz; Augustynowicz, Anna.
Affiliation
  • Switalski J; Department of Health Economics and Medical Law, Faculty of Health Sciences, Medical University of Warsaw, 01-445 Warsaw, Poland. Electronic address: jakub.switalski@wum.edu.pl.
  • Miazga W; Department of Health Policy Programs, Department of Health Technology Assessment, Agency for Health Technology Assessment and Tariff System, 00-032 Warsaw, Poland; School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland. Electronic address: w.miazga@aotm.go
  • Wnuk K; Department of Health Policy Programs, Department of Health Technology Assessment, Agency for Health Technology Assessment and Tariff System, 00-032 Warsaw, Poland; School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland. Electronic address: k.wnuk@aotm.gov.
  • Tatara T; Department of Public Health, Faculty of Health Sciences, Medical University of Warsaw, 02-091 Warsaw, Poland. Electronic address: ttatara@wum.edu.pl.
  • Olszewski P; Medical Faculty, Lazarski University, 02-662 Warsaw, Poland. Electronic address: p.olszewski@lazarski.edu.pl.
  • Jankowski M; School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland. Electronic address: mateusz.jankowski@cmkp.edu.pl.
  • Augustynowicz A; Department of Health Economics and Medical Law, Faculty of Health Sciences, Medical University of Warsaw, 01-445 Warsaw, Poland; School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland. Electronic address: anna.augustynowicz@wum.edu.pl.
Vaccine ; 42(15): 3461-3466, 2024 May 31.
Article in En | MEDLINE | ID: mdl-38653680
ABSTRACT

INTRODUCTION:

Meningococcal vaccinations are recommended by Polish public health authorities but lack coverage under health insurance, prompting Local Government Units (LGUs) to implement local health policy programs. This study examines the effectiveness and impact of LGU-driven meningococcal vaccination initiatives in Poland between 2017 and 2021. MATERIAL AND

METHODS:

A retrospective analysis utilized data from reports on local public health interventions submitted annually to the Ministry of Health in Poland. The study focused on the number of meningococcal vaccination programs, their scope, the vaccinated population, and associated program costs. Additionally, nationwide data on meningococcal disease incidence and vaccine uptake were analyzed.

RESULTS:

Within LGUs programs, 48,617 individuals received meningococcal vaccinations, constituting approximately 10% of all vaccinations in Poland during the study period. Notably, cities with poviat rights spearheaded programs covering 54% of the total participants. The total cost incurred by these initiatives amounted to EUR 2,553,661.

CONCLUSIONS:

While LGUs activities positively contributed to increased meningococcal vaccination rates, the overall engagement of local governments remains limited. The findings underscore the importance of expanding local government involvement in meningococcal vaccination programs to address public health needs effectively. Improved collaboration and increased funding may enhance the reach and impact of these initiatives.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization Programs / Meningococcal Vaccines / Meningococcal Infections / Local Government Limits: Humans Country/Region as subject: Europa Language: En Journal: Vaccine Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization Programs / Meningococcal Vaccines / Meningococcal Infections / Local Government Limits: Humans Country/Region as subject: Europa Language: En Journal: Vaccine Year: 2024 Document type: Article